Advances in the diagnosis and treatment of onychomycosis
Journal Title: Postępy Dermatologii i Alergologii - Year 2006, Vol 23, Issue 3
Abstract
Prevalence of the onychomycosis increases every year. To optimize treatment the pathogens have to be identified. Mycological examination is currently a gold standard for the diagnosis but other diagnostic tools e.g. molecular genetic techniques are developed. Also many modifications of the standard diagnostic examination, which improve its sensitivity and specificity, are present. In the treatment three main strategies are present now: topical, oral and combination. The new regimens of oral and topical treatment are proposed and new antifungals which were recently developed broaden the treatment possibilities. Despite many protocols, the current treatment rate is still disappointing, and many reasons of the failure are considered. The main one is probably poor penetration of the drug into the affected nail. Pharmacokinetic researches proved that concentrations of the medicine in a healthy nail plate are much higher than in the lesional one. Also relapses and reinfections remain stubborn problems in the management of the onychomycosis.
Authors and Affiliations
Wojciech Baran, Aleksandra Batycka, Eugeniusz Baran
The usefulness of radiotherapy in treatment of benign familial pemphigus
Hailey-Hailey disease (HHD), or familial benign chronic pemphigus, is an autosomal dominant genodermatosis. The symptoms of the disease (itching, pain, burning) may lead, in some cases, to a lowering in the quality of li...
Placebo effect in treatment of pain associated with venous leg ulcers
Venous leg ulcers constitute a major therapeutic and social problem. This chronic recurrent condition concerns mostly elderly patients, often suffering from a number of other diseases, thus adding to their disability. Lo...
Rozpuszczalne receptory CD30 i CD26 w surowicy krwi chorych na atopowe zapalenie skóry jako markery stopnia nasilenia procesu chorobowego
Atopowe zapalenie skóry (AZS) jest przewlekłą, nawrotową, zapalną chorobą skóry, której częstość występowania jest coraz wyższa. Etiopatogeneza AZS jest wieloczynnikowa i nadal nie do końca poznana. Szczególnie ważne wyd...
Sprawozdanie z Sympozjum Naukowo-Szkoleniowego Sekcji Alergologicznej Polskiego Towarzystwa Dermatologicznego Choroby alergiczne skóry
Substance P, vasoactive intestinal peptide and nerve growth factor involvement in the pathogenesis of few dermatoses
Neuropeptides act as neuromodulators, neurotransmitters, neurotrophins and neurohormons and are involved in the transmission of signals between nerve cells and immune cells. They are produced mostly in afferent, unmyelin...